F2RL1 and hepatocellular carcinoma: Therefore, we specifically addressed this issue by evaluating the effect of PAR2 silencing in the HSC cell line LX-2 [46] on tumour growth in a SCID mouse xenograft model, in which a HCC was induced by (co)injection of LX-2 cells and Hep3B liver carcinoma cells.